Saúl Reyes

842 total citations
38 papers, 496 citations indexed

About

Saúl Reyes is a scholar working on Pathology and Forensic Medicine, Neurology and Infectious Diseases. According to data from OpenAlex, Saúl Reyes has authored 38 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 14 papers in Neurology and 7 papers in Infectious Diseases. Recurrent topics in Saúl Reyes's work include Multiple Sclerosis Research Studies (15 papers), Peripheral Neuropathies and Disorders (5 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Saúl Reyes is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Peripheral Neuropathies and Disorders (5 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Saúl Reyes collaborates with scholars based in Colombia, United Kingdom and United States. Saúl Reyes's co-authors include Gavin Giovannoni, Sharmilee Gnanapavan, Carolina Ferreira‐Atuesta, Klaus Schmierer, Mónica Marta, David Baker, Gareth Pryce, Sandra Amor, Angray S. Kang and Ruth Dobson and has published in prestigious journals such as New England Journal of Medicine, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Saúl Reyes

29 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saúl Reyes Colombia 10 300 167 147 59 53 38 496
Olivier Heinzlef France 10 383 1.3× 201 1.2× 205 1.4× 110 1.9× 41 0.8× 25 604
Michael Guger Austria 12 207 0.7× 103 0.6× 160 1.1× 94 1.6× 54 1.0× 38 425
Pablo A. López Argentina 12 286 1.0× 80 0.5× 171 1.2× 39 0.7× 30 0.6× 53 449
Kévin Bigaut France 12 379 1.3× 337 2.0× 374 2.5× 119 2.0× 66 1.2× 28 671
Edlin Gonzales United States 11 247 0.8× 75 0.4× 79 0.5× 56 0.9× 128 2.4× 15 428
Sonu M. Brara United States 8 436 1.5× 66 0.4× 152 1.0× 53 0.9× 117 2.2× 11 667
Brandon Beaber United States 8 458 1.5× 65 0.4× 115 0.8× 57 1.0× 141 2.7× 12 640
Nada Abou-Fayssal United States 5 122 0.4× 89 0.5× 119 0.8× 55 0.9× 22 0.4× 7 247
Pål Berg‐Hansen Norway 16 475 1.6× 38 0.2× 148 1.0× 70 1.2× 118 2.2× 40 699
Stéphane Debeugny France 8 200 0.7× 32 0.2× 176 1.2× 39 0.7× 77 1.5× 18 537

Countries citing papers authored by Saúl Reyes

Since Specialization
Citations

This map shows the geographic impact of Saúl Reyes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saúl Reyes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saúl Reyes more than expected).

Fields of papers citing papers by Saúl Reyes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saúl Reyes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saúl Reyes. The network helps show where Saúl Reyes may publish in the future.

Co-authorship network of co-authors of Saúl Reyes

This figure shows the co-authorship network connecting the top 25 collaborators of Saúl Reyes. A scholar is included among the top collaborators of Saúl Reyes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saúl Reyes. Saúl Reyes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Butzkueven, Helmut, Cristoforo Comi, Kathleen Costello, et al.. (2025). Brain health – time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions. 2024 report. Multiple Sclerosis and Related Disorders. 101. 106456–106456.
3.
Contentti, Edgar Carnero, Ethel Ciampi, Sheila Castro‐Suárez, et al.. (2024). The real‐world applicability of the 2023 international myelin oligodendrocyte glycoprotein antibody‐associated disease criteria in a Latin American cohort. European Journal of Neurology. 31(12). e16445–e16445. 3 indexed citations
4.
Cheng, Aristine, et al.. (2024). Anti-IL12p40 autoantibodies in a teenage girl with multiple recurrent abscesses. Clinical Immunology. 266. 110335–110335.
6.
Otero‐Romero, Susana, Christine Lebrun‐Frénay, Saúl Reyes, et al.. (2023). ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs. Multiple Sclerosis Journal. 29(8). 904–925. 22 indexed citations
7.
Dobson, Ruth, Dylan R. Rice, Marie D’hooghe, et al.. (2022). Social determinants of health in multiple sclerosis. Nature Reviews Neurology. 18(12). 723–734. 65 indexed citations
8.
Reyes, Saúl, Anthony L. Cunningham, Tomáš Kalinčík, et al.. (2021). Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement. Journal of Neuroimmunology. 357. 577627–577627. 32 indexed citations
9.
Reyes, Saúl, Mary Ramsay, Shamez Ladhani, et al.. (2020). Protecting people with multiple sclerosis through vaccination. Practical Neurology. 20(6). 435.1–445. 36 indexed citations
10.
Reyes, Saúl, et al.. (2020). Vitamin D and other environmental risk factors in Colombian patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 41. 101983–101983. 4 indexed citations
11.
Reyes, Saúl, Sebastián Suárez, Özlem Kayım Yıldız, et al.. (2020). Socioeconomic status and disease-modifying therapy prescribing patterns in people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 41. 102024–102024. 6 indexed citations
12.
Smets, Ide, Saúl Reyes, & Gavin Giovannoni. (2020). Distinguishing physiological versus pathological serum NfL levels in multiple sclerosis will require serial measurements. Multiple Sclerosis and Related Disorders. 46. 102477–102477. 2 indexed citations
13.
Reyes, Saúl, et al.. (2020). Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not?. eNeurologicalSci. 21. 100279–100279. 4 indexed citations
14.
Reyes, Saúl, et al.. (2020). Severe skin reactions associated with cladribine in people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 43. 102140–102140. 4 indexed citations
15.
Reyes, Saúl, Benjamin Turner, Joela Mathews, et al.. (2019). Severe skin reactions associated with Cladribine treatment in patients with multiple sclerosis (P4.2-022). Neurology. 92(15_supplement).
16.
Reyes, Saúl, et al.. (2018). Social capital: Implications for neurology. Brain and Behavior. 9(1). e01169–e01169. 8 indexed citations
17.
Sullivan, Kathleen E., Hamid Bassiri, Ahmed Aziz Bousfiha, et al.. (2017). Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies. Journal of Clinical Immunology. 37(7). 650–692. 5 indexed citations
18.
Reyes, Saúl, et al.. (2014). Tongue Fasciculations in Amyotrophic Lateral Sclerosis. New England Journal of Medicine. 371(5). e7–e7. 2 indexed citations
19.
Porras, Alexandra, et al.. (2014). The transition to a teaching hospital: Patient satisfaction before and after the introduction of medical students. Medical Teacher. 36(8). 710–714. 13 indexed citations
20.
Reyes, Saúl, et al.. (2013). Neuroimaging in amyotrophic lateral sclerosis. BMJ Case Reports. 2013. bcr2013201416–bcr2013201416.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026